- Home
- AACG vs BNR Comparison
AACG vs BNR Comparison
Compare AACG & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- BNR
- Stock Information
- Founded
- AACG 1999
- BNR 2014
- Country
- AACG China
- BNR China
- Employees
- AACG N/A
- BNR N/A
- Industry
- AACG Other Consumer Services
- BNR Medical Specialities
- Sector
- AACG Real Estate
- BNR Health Care
- Exchange
- AACG Nasdaq
- BNR Nasdaq
- Market Cap
- AACG 65.1M
- BNR 38.3M
- IPO Year
- AACG N/A
- BNR 2020
- Fundamental
- Price
- AACG $2.52
- BNR $8.38
- Analyst Decision
- AACG
- BNR
- Analyst Count
- AACG 0
- BNR 0
- Target Price
- AACG N/A
- BNR N/A
- AVG Volume (30 Days)
- AACG 75.6K
- BNR 52.2K
- Earning Date
- AACG 11-06-2025
- BNR 09-08-2025
- Dividend Yield
- AACG N/A
- BNR N/A
- EPS Growth
- AACG N/A
- BNR N/A
- EPS
- AACG N/A
- BNR N/A
- Revenue
- AACG $39,064,701.00
- BNR $74,862,782.00
- Revenue This Year
- AACG N/A
- BNR $136.32
- Revenue Next Year
- AACG N/A
- BNR N/A
- P/E Ratio
- AACG N/A
- BNR N/A
- Revenue Growth
- AACG 15.19
- BNR 5.20
- 52 Week Low
- AACG $0.50
- BNR $2.18
- 52 Week High
- AACG $2.50
- BNR $11.12
- Technical
- Relative Strength Index (RSI)
- AACG 58.02
- BNR 51.95
- Support Level
- AACG $1.77
- BNR $8.30
- Resistance Level
- AACG $2.18
- BNR $9.55
- Average True Range (ATR)
- AACG 0.17
- BNR 0.69
- MACD
- AACG -0.12
- BNR -0.15
- Stochastic Oscillator
- AACG 97.59
- BNR 30.57
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.